John Mandrola, MD, a seasoned cardiologist, and Sripal Bangalore, a cardiac research expert, delve into some urgent issues in cardiology. They discuss the implications of FDA Class I device recalls and the troubling disparities in preventive care access for marginalized patients. The duo also tackles the risks of prematurely stopping clinical trials and the impact of potassium management on post-surgery outcomes. Plus, listeners are updated on the positive results of the SHAM-PVI trial for AF ablation, revealing its intriguing effects.
